FDA inspection
Novo Nordisk Pharmaceutical Industries LP: FDA inspection ending Jun 13, 2025
FDA inspection 1269778 · No Action Indicated (NAI) · Clayton, NC
Key facts
| Inspection ID | 1269778 |
|---|---|
| Firm | Novo Nordisk Pharmaceutical Industries LP |
| FEI number | 1000158576 |
| Address | 3612 Powhatan Rd |
| City | Clayton |
| State | NC |
| ZIP | 27527 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Jun 13, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data